CVE-2026-103473: denoland deno

Deno 2.7.0 through 2.9.7 Command Injection via node:child_process

CVSS 9.2 CriticalCriticalEPSS 0.015 · 73rd percentile

Critical, because:

CVSS score 9.2: 9.0 or more.

Published by the CVE Program (CNA: VulnCheck) at 30 Sept 2026, 17:22 UTC. agentprime has not analysed this yet, so whether it affects any app is not known. This CVE names a vendor and product rather than a package, so the lockfile check doesn’t match it.

Affected products, as the CNA wrote them
Vendor	Product	Versions
denoland	deno	affected 2.7.0 to 2.9.7, inclusive custom Other versions: unaffected

Identifiers

CVE-2026-103473

CNA

VulnCheck

Weakness (CWE)

CWE-78

Not analysed yet

We haven’t published our own analysis of this CVE. If a person reviews it, this page will say what’s affected and what has to be true for it to matter.

Severity and exploitation

Score	Rating	CVSS	Vector	Source
9.2	Critical	4.0	CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N	CNA (VulnCheck)Used for this record
8.1	High	3.1	CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H	CNA (VulnCheck)

CISA KEV Not listed.
EPSS 0.015, the 73rd percentile, on 10 Nov 2026: FIRST’s estimate of the chance of exploitation in the next 30 days.

Timeline

This record came from the full history of the CVE Program, published 30 Sept 2026. New records show when each source confirmed them.

Sources

References from the CNA

github.com/denoland/deno/pull/36772 issue-trackingpatch
github.com/denoland/deno product
github.com/denoland/deno/blob/0c071246a412575e07423263404a5d13e7ed6aa2/ext/node/polyfills/internal/child_process.ts#L1499 technical-description
github.com/denoland/deno/blob/0c071246a412575e07423263404a5d13e7ed6aa2/ext/node/polyfills/internal/child_process.ts#L1339 technical-description
www.vulncheck.com/advisories/deno-2.7.0-through-2.9.7-command-injection-via-node-child-process third-party-advisory

Facts on this page come from the CVE List as the CNA published them, with CVSS from the sources named above, CISA KEV and FIRST EPSS. Vendors, products and versions are shown as the CNA wrote them. We don’t reproduce the CVE’s description.